{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:21:31Z","timestamp":1790623291132,"version":"4.1.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL144539"],"award-info":[{"award-number":["R01HL144539"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P50DK096373-11"],"award-info":[{"award-number":["P50DK096373-11"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SWIATE24A0-MPI"],"award-info":[{"award-number":["SWIATE24A0-MPI"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SKOPEL24A0-MPI"],"award-info":[{"award-number":["SKOPEL24A0-MPI"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["HARRIS24A0-MPI"],"award-info":[{"award-number":["HARRIS24A0-MPI"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["P50DK096373-11"],"award-info":[{"award-number":["P50DK096373-11"]}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["P20GM130454-04"],"award-info":[{"award-number":["P20GM130454-04"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["P30DK117469"],"award-info":[{"award-number":["P30DK117469"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cystic fibrosis (CF) is a life-shortening multisystem disease resulting from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, causing the most devastating phenotypes in the airway and pancreas. Significant advances in treatment for CF lung disease, including the expanded use of high-efficiency modulator therapies (HEMT) such as Trikafta, have dramatically increased both quality of life and life expectancy for people with CF (PwCF). With these advances, long-term extrapulmonary manifestations are more frequently recognized. Pseudo-Barter syndrome, acute kidney injury (AKI) induced by medications or dehydration, amyloidosis, nephrolithiasis, and IgA and diabetic nephropathies have been previously reported in PwCF. Newer data suggest that chronic kidney disease (CKD) is a new morbidity in the aging CF population, affecting 19% of people over age 55. CKD carries a high risk of premature death from cardiovascular complications. Studies suggest that CFTR dysfunction increases kidneys\u2019 vulnerability to injury caused by the downstream effects of CF. Improving the mutant CFTR function by HEMT may help to tease apart the kidney responses resulting from extrinsic factors and those intrinsically related to the\n                    <jats:italic>CFTR<\/jats:italic>\n                    gene mutations. Additionally, given the novelty of HEMT approaches, the potential off-target effects of their long-term use are currently unknown. We review the evolving kidney complications in PwCF and propose the term CF-related kidney disease. We hope this review will increase awareness about the changing phenotype of kidney dysfunction in PwCF and help prevent morbidity related to this condition.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s00467-025-06715-3","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T09:17:21Z","timestamp":1742203041000},"page":"3605-3614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cystic fibrosis\u2013related kidney disease\u2014emerging morbidity and disease modifier"],"prefix":"10.1007","volume":"40","author":[{"given":"Merrill","family":"Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu Ballav","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Tom","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sladjana","family":"Skopelja-Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Swiatecka-Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"6715_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","volume":"21","author":"J Guo","year":"2022","unstructured":"Guo J, Garratt A, Hill A (2022) Worldwide rates of diagnosis and effective treatment for cystic fibrosis. J Cyst Fibros 21:456\u2013462. https:\/\/doi.org\/10.1016\/j.jcf.2022.01.009","journal-title":"J Cyst Fibros"},{"key":"6715_CR2","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","volume":"397","author":"M Shteinberg","year":"2021","unstructured":"Shteinberg M, Haq IJ, Polineni D, Davies JC (2021) Cystic fibrosis. Lancet 397:2195\u20132211. https:\/\/doi.org\/10.1016\/S0140-6736(20)32542-3","journal-title":"Lancet"},{"key":"6715_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1085\/jgp.201110705","volume":"138","author":"Y Bai","year":"2011","unstructured":"Bai Y, Li M, Hwang TC (2011) Structural basis for the channel function of a degraded ABC transporter, CFTR (ABCC7). J Gen Physiol 138:495\u2013507. https:\/\/doi.org\/10.1085\/jgp.201110705","journal-title":"J Gen Physiol"},{"key":"6715_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","volume":"74","author":"V Saint-Criq","year":"2017","unstructured":"Saint-Criq V, Gray MA (2017) Role of CFTR in epithelial physiology. Cell Molec Life Sci 74:93\u2013115. https:\/\/doi.org\/10.1007\/s00018-016-2391-y","journal-title":"Cell Molec Life Sci"},{"key":"6715_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/im9.0000000000000101","volume":"4","author":"R Siew","year":"2022","unstructured":"Siew R, Ou TL, Dahesh S, Akong K, Nizet V (2022) Bicarbonate effects on antibacterial immunity and mucus glycobiology in the cystic fibrosis lung: a review with selected experimental observations. Infect Microbes Dis 4:103\u2013110. https:\/\/doi.org\/10.1097\/im9.0000000000000101","journal-title":"Infect Microbes Dis"},{"key":"6715_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11130","volume":"487","author":"AA Pezzulo","year":"2012","unstructured":"Pezzulo AA, Tang XX, Hoegger MJ, Abou Alaiwa MH, Ramachandran S, Moninger TO, Karp PH, Wohlford-Lenane CL, Haagsman HP, van Eijk M, Banfi B, Horswill AR, Stoltz DA, McCray PB Jr, Welsh MJ, Zabner J (2012) Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 487:109\u2013113. https:\/\/doi.org\/10.1038\/nature11130","journal-title":"Nature"},{"key":"6715_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/archpedi.1946.02020300069004","volume":"72","author":"DH Andersen","year":"1911","unstructured":"Andersen DH (1911) Hodges RG (1946) Celiac syndrome; genetics of cystic fibrosis of the pancreas, with a consideration of etiology. Am J Dis Child 72:62\u201380. https:\/\/doi.org\/10.1001\/archpedi.1946.02020300069004","journal-title":"Am J Dis Child"},{"key":"6715_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.prrv.2020.05.002","volume":"42","author":"IM Balfour-Lynn","year":"2022","unstructured":"Balfour-Lynn IM, King JA (2022) CFTR modulator therapies - effect on life expectancy in people with cystic fibrosis. Paediatr Respir Rev 42:3\u20138. https:\/\/doi.org\/10.1016\/j.prrv.2020.05.002","journal-title":"Paediatr Respir Rev"},{"key":"6715_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41572-024-00538-6","volume":"10","author":"MA Mall","year":"2024","unstructured":"Mall MA, Burgel PR, Castellani C, Davies JC, Salathe M, Taylor-Cousar JL (2024) Cystic fibrosis Nat Rev Dis Primers 10:53. https:\/\/doi.org\/10.1038\/s41572-024-00538-6","journal-title":"Cystic fibrosis Nat Rev Dis Primers"},{"key":"6715_CR10","doi-asserted-by":"publisher","first-page":"e29359","DOI":"10.7759\/cureus.29359","volume":"14","author":"SN Dawood","year":"2022","unstructured":"Dawood SN, Rabih AM, Niaj A, Raman A, Uprety M, Calero MJ, Villanueva MRB, Joshaghani N, Villa N, Badla O, Goit R, Saddik SE, Mohammed L (2022) Newly discovered cutting-edge triple combination cystic fibrosis therapy: a systematic review. Cureus 14:e29359. https:\/\/doi.org\/10.7759\/cureus.29359","journal-title":"Cureus"},{"key":"6715_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0092-8674(90)90148-8","volume":"63","author":"SH Cheng","year":"1990","unstructured":"Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O\u2019Riordan CR, Smith AE (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63:827\u2013834. https:\/\/doi.org\/10.1016\/0092-8674(90)90148-8","journal-title":"Cell"},{"key":"6715_CR12","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.chest.2021.11.001","volume":"161","author":"M Chin","year":"2022","unstructured":"Chin M, Brennan AL, Bell SC (2022) Emerging nonpulmonary complications for adults with cystic fibrosis: adult cystic fibrosis series. Chest 161:1211\u20131224. https:\/\/doi.org\/10.1016\/j.chest.2021.11.001","journal-title":"Chest"},{"key":"6715_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jcf.2013.03.005","volume":"12","author":"D Nazareth","year":"2013","unstructured":"Nazareth D, Walshaw M (2013) A review of renal disease in cystic fibrosis. J Cyst Fibros 12:309\u2013317. https:\/\/doi.org\/10.1016\/j.jcf.2013.03.005","journal-title":"J Cyst Fibros"},{"key":"6715_CR14","first-page":"879","volume":"110","author":"RC McGlennen","year":"1986","unstructured":"McGlennen RC, Burke BA, Dehner LP (1986) Systemic amyloidosis complicating cystic fibrosis. A retrospective pathologic study. Arch Pathol Lab Med 110:879\u2013884","journal-title":"Arch Pathol Lab Med"},{"key":"6715_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2215\/CJN.00750209","volume":"4","author":"Y Yahiaoui","year":"2009","unstructured":"Yahiaoui Y, Jablonski M, Hubert D, Mosnier-Pudar H, Noel LH, Stern M, Grenet D, Grunfeld JP, Chauveau D, Fakhouri F (2009) Renal involvement in cystic fibrosis: diseases spectrum and clinical relevance. Clin J Am Soc Nephrol 4:921\u2013928. https:\/\/doi.org\/10.2215\/CJN.00750209","journal-title":"Clin J Am Soc Nephrol"},{"key":"6715_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.kint.2022.10.028","volume":"103","author":"S Karam","year":"2023","unstructured":"Karam S, Haidous M, Royal V, Leung N (2023) Renal AA amyloidosis: presentation, diagnosis, current therapeutic options: a review. Kidney Int 103:473\u2013484. https:\/\/doi.org\/10.1016\/j.kint.2022.10.028","journal-title":"Kidney Int"},{"key":"6715_CR17","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1016\/j.ekir.2024.04.044","volume":"9","author":"TN Caza","year":"2024","unstructured":"Caza TN, Walker PD (2024) Clinicopathologic features of kidney disease in patients with cystic fibrosis. Kidney Int Rep 9:2286\u20132289. https:\/\/doi.org\/10.1016\/j.ekir.2024.04.044","journal-title":"Kidney Int Rep"},{"key":"6715_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.semnephrol.2018.05.013","volume":"38","author":"FP Schena","year":"2018","unstructured":"Schena FP, Nistor I (2018) Epidemiology of IgA nephropathy: a global perspective. Sem Nephrol 38:435\u2013442. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.05.013","journal-title":"Sem Nephrol"},{"key":"6715_CR19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.2183\/pjab.93.046","volume":"93","author":"J Nojima","year":"2017","unstructured":"Nojima J, Meguro S, Ohkawa N, Furukoshi M, Kawai T, Itoh H (2017) One-year eGFR decline rate is a good predictor of prognosis of renal failure in patients with type 2 diabetes. Proc Jpn Acad Ser B Phys Biol Sci 93:746\u2013754. https:\/\/doi.org\/10.2183\/pjab.93.046","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"6715_CR20","doi-asserted-by":"publisher","first-page":"10165","DOI":"10.1038\/s41598-021-89442-7","volume":"11","author":"T Waas","year":"2021","unstructured":"Waas T, Schulz A, Lotz J, Rossmann H, Pfeiffer N, Beutel ME, Schmidtmann I, Munzel T, Wild PS, Lackner KJ (2021) Distribution of estimated glomerular filtration rate and determinants of its age dependent loss in a German population-based study. Sci Rep 11:10165. https:\/\/doi.org\/10.1038\/s41598-021-89442-7","journal-title":"Sci Rep"},{"key":"6715_CR21","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1164\/rccm.201105-0932OC","volume":"184","author":"BS Quon","year":"2011","unstructured":"Quon BS, Mayer-Hamblett N, Aitken ML, Smyth AR, Goss CH (2011) Risk factors for chronic kidney disease in adults with cystic fibrosis. Am J Respir Crit Care Med 184:1147\u20131152. https:\/\/doi.org\/10.1164\/rccm.201105-0932OC","journal-title":"Am J Respir Crit Care Med"},{"key":"6715_CR22","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1164\/rccm.201108-1554ED","volume":"184","author":"MS Schechter","year":"2011","unstructured":"Schechter MS, Stecenko AA (2011) Chronic kidney disease: a new morbidity of cystic fibrosis or an old morbidity of diabetes mellitus? Am J Respir Crit Care Med 184:1101\u20131102. https:\/\/doi.org\/10.1164\/rccm.201108-1554ED","journal-title":"Am J Respir Crit Care Med"},{"key":"6715_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fmed.2018.00242","volume":"5","author":"ACH Nowakowski","year":"2018","unstructured":"Nowakowski ACH (2018) Cystic fibrosis kidney disease: 10 Tips for Clinicians. Front Med (Lausanne) 5:242. https:\/\/doi.org\/10.3389\/fmed.2018.00242","journal-title":"Front Med (Lausanne)"},{"key":"6715_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12967-019-02139-4","volume":"17","author":"S Lai","year":"2019","unstructured":"Lai S, Mazzaferro S, Mitterhofer AP, Bonci E, Marotta PG, Pelligra F, Murciano M, Celani C, Troiani P, Cimino G, Palange P (2019) Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis. J Transl Med 17:388. https:\/\/doi.org\/10.1186\/s12967-019-02139-4","journal-title":"J Transl Med"},{"key":"6715_CR25","doi-asserted-by":"publisher","first-page":"117955142110312","DOI":"10.1177\/11795514211031204","volume":"14","author":"E Westholm","year":"2021","unstructured":"Westholm E, Wendt A, Eliasson L (2021) Islet Function in the pathogenesis of cystic fibrosis-related diabetes mellitus. Clin Med Insights Endocrinol Diabetes 14:11795514211031204. https:\/\/doi.org\/10.1177\/11795514211031204","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"6715_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jcf.2008.05.008","volume":"7","author":"JM van den Berg","year":"2008","unstructured":"van den Berg JM, Morton AM, Kok SW, Pijl H, Conway SP, Heijerman HG (2008) Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD). J Cyst Fibros 7:515\u2013519. https:\/\/doi.org\/10.1016\/j.jcf.2008.05.008","journal-title":"J Cyst Fibros"},{"key":"6715_CR27","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jcf.2017.11.001","volume":"17","author":"KH Berg","year":"2018","unstructured":"Berg KH, Ryom L, Faurholt-Jepsen D, Pressler T, Katzenstein TL (2018) Prevalence and characteristics of chronic kidney disease among Danish adults with cystic fibrosis. J Cyst Fibros 17:478\u2013483. https:\/\/doi.org\/10.1016\/j.jcf.2017.11.001","journal-title":"J Cyst Fibros"},{"key":"6715_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ppul.20138","volume":"39","author":"M Al-Aloul","year":"2005","unstructured":"Al-Aloul M, Miller H, Alapati S, Stockton PA, Ledson MJ, Walshaw MJ (2005) Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulm 39:15\u201320. https:\/\/doi.org\/10.1002\/ppul.20138","journal-title":"Pediatr Pulm"},{"key":"6715_CR29","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1038\/s41598-018-23466-4","volume":"8","author":"SJ McWilliam","year":"2018","unstructured":"McWilliam SJ, Antoine DJ, Jorgensen AL, Smyth RL, Pirmohamed M (2018) Urinary biomarkers of aminoglycoside-induced nephrotoxicity in cystic fibrosis: kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin. Sci Rep 8:5094. https:\/\/doi.org\/10.1038\/s41598-018-23466-4","journal-title":"Sci Rep"},{"key":"6715_CR30","doi-asserted-by":"publisher","unstructured":"Burrows NR, Koyama A, Pavkov ME (2022) Reported cases of end-stage kidney disease - United States, 2000\u20132019. Morb Mortal Wkly Rep 71:412\u2013415. https:\/\/doi.org\/10.15585\/mmwr.mm7111a3","DOI":"10.15585\/mmwr.mm7111a3"},{"key":"6715_CR31","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/pubmed\/fdab112","volume":"44","author":"A Florea","year":"2022","unstructured":"Florea A, Jacobs ET, Harris RB, Klimentidis YC, Thajudeen B, Kohler LN (2022) Chronic kidney disease unawareness and determinants using 1999\u20132014 National Health and Nutrition Examination Survey data. J Public Health (Oxf) 44:532\u2013540. https:\/\/doi.org\/10.1093\/pubmed\/fdab112","journal-title":"J Public Health (Oxf)"},{"key":"6715_CR32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, Bohm M, Marx N (2021) Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143:1157\u20131172. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050686","journal-title":"Circulation"},{"key":"6715_CR33","doi-asserted-by":"publisher","first-page":"100604","DOI":"10.1016\/j.xkme.2023.100604","volume":"5","author":"NK Rai","year":"2023","unstructured":"Rai NK, Wang Z, Drawz PE, Connett J, Murphy DP (2023) CKD progression risk and subsequent cause of death: a population-based cohort study. Kidney Med 5:100604. https:\/\/doi.org\/10.1016\/j.xkme.2023.100604","journal-title":"Kidney Med"},{"key":"6715_CR34","doi-asserted-by":"publisher","first-page":"e078063","DOI":"10.1136\/bmj-2023-078063","volume":"385","author":"P Liu","year":"2024","unstructured":"Liu P, Sawhney S, Heide-Jorgensen U, Quinn RR, Jensen SK, McLean A, Christiansen CF, Gerds TA, Ravani P (2024) Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease: multinational, longitudinal, population based, cohort study. BMJ 385:e078063. https:\/\/doi.org\/10.1136\/bmj-2023-078063","journal-title":"BMJ"},{"issue":"4","key":"6715_CR35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.34067\/KID.0000000000000097","volume":"360","author":"AJ Kula","year":"2023","unstructured":"Kula AJ, Prince DK, Katz R, Bansal N (2023) Mortality burden and life-years lost across the age spectrum for adults living with CKD. Kidney360 4:615\u2013621. https:\/\/doi.org\/10.34067\/KID.0000000000000097","journal-title":"Kidney"},{"key":"6715_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2024.12.007","author":"GM Rosner","year":"2025","unstructured":"Rosner GM, Goswami HB, Sessions K, Mendyka LK, Kerin B, Vlasac I, Mellinger D, Gwilt L, Hampton TH, Graber M, Ashare A, Harris WT, Christensen B, Stanton BA, Swiatecka-Urban A, Skopelja-Gardner S (2025) Lung-kidney axis in cystic fibrosis: early urinary markers of kidney injury correlate with neutrophil activation and worse lung function. J Cyst Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2024.12.007","journal-title":"J Cyst Fibros"},{"key":"6715_CR37","doi-asserted-by":"publisher","first-page":"2301253","DOI":"10.1183\/13993003.01253-2023","volume":"62","author":"H Hebestreit","year":"2023","unstructured":"Hebestreit H, Thornton CS (2023) Cystic fibrosis and the cardiovascular system: the unexpected heartache. Eur Resp J 62:2301253. https:\/\/doi.org\/10.1183\/13993003.01253-2023","journal-title":"Eur Resp J"},{"key":"6715_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1056\/NEJM198808043190502","volume":"319","author":"SM Katz","year":"1988","unstructured":"Katz SM, Krueger LJ, Falkner B (1988) Microscopic nephrocalcinosis in cystic fibrosis. N Engl J Med 319:263\u2013266. https:\/\/doi.org\/10.1056\/NEJM198808043190502","journal-title":"N Engl J Med"},{"key":"6715_CR39","first-page":"22","volume":"46","author":"U Oz\u00e7elik","year":"2004","unstructured":"Oz\u00e7elik U, Be\u015fba\u015f N, G\u00f6\u00e7men A, Akata D, Akhan O, Ozg\u00fc\u00e7 M, Kiper N (2004) Hypercalciuria and nephrocalcinosis in cystic fibrosis patients. Turk J Pediatr 46:22\u201327","journal-title":"Turk J Pediatr"},{"key":"6715_CR40","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/s0022-3476(05)81602-6","volume":"116","author":"L Bentur","year":"1990","unstructured":"Bentur L, Kerem E, Couper R, Baumal R, Canny G, Durie P, Levison H (1990) Renal calcium handling in cystic fibrosis: lack of evidence for a primary renal defect. J Pediatr 116:556\u2013560. https:\/\/doi.org\/10.1016\/s0022-3476(05)81602-6","journal-title":"J Pediatr"},{"key":"6715_CR41","doi-asserted-by":"publisher","first-page":"1381174","DOI":"10.3389\/fgene.2024.1381174","volume":"15","author":"AM Gefen","year":"2024","unstructured":"Gefen AM, Zaritsky JJ (2024) Review of childhood genetic nephrolithiasis and nephrocalcinosis. Front Genet 15:1381174. https:\/\/doi.org\/10.3389\/fgene.2024.1381174","journal-title":"Front Genet"},{"key":"6715_CR42","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/ndt\/gfu307","volume":"30","author":"M Soleimani","year":"2015","unstructured":"Soleimani M (2015) The multiple roles of pendrin in the kidney. Nephrol Dial Transplant 30:1257\u20131266. https:\/\/doi.org\/10.1093\/ndt\/gfu307","journal-title":"Nephrol Dial Transplant"},{"key":"6715_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0272-6386(03)00403-7","volume":"42","author":"EM Gibney","year":"2003","unstructured":"Gibney EM, Goldfarb DS (2003) The association of nephrolithiasis with cystic fibrosis. Am J Kidney Dis 42:1\u201311. https:\/\/doi.org\/10.1016\/s0272-6386(03)00403-7","journal-title":"Am J Kidney Dis"},{"key":"6715_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0002-9343(01)00740-9","volume":"111","author":"DR Gutknecht","year":"2001","unstructured":"Gutknecht DR (2001) Kidney stones and cystic fibrosis. Am J Med 111:83. https:\/\/doi.org\/10.1016\/S0002-9343(01)00740-9","journal-title":"Am J Med"},{"key":"6715_CR45","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/ndt\/gfl067","volume":"21","author":"M Terribile","year":"2006","unstructured":"Terribile M, Capuano M, Cangiano G, Carnovale V, Ferrara P, Petrarulo M, Marangella M (2006) Factors increasing the risk for stone formation in adult patients with cystic fibrosis. Nephrol Dial Transplant 21:1870\u20131875. https:\/\/doi.org\/10.1093\/ndt\/gfl067","journal-title":"Nephrol Dial Transplant"},{"key":"6715_CR46","doi-asserted-by":"publisher","first-page":"F723","DOI":"10.1152\/ajprenal.1996.271.3.F723","volume":"271","author":"O Devuyst","year":"1996","unstructured":"Devuyst O, Burrow CR, Schwiebert EM, Guggino WB, Wilson PD (1996) Developmental regulation of CFTR expression during human nephrogenesis. Am J Physiol 271:F723-735. https:\/\/doi.org\/10.1152\/ajprenal.1996.271.3.F723","journal-title":"Am J Physiol"},{"key":"6715_CR47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1590\/s0001-37652000000300013","volume":"72","author":"MM Morales","year":"2000","unstructured":"Morales MM, Falkenstein D, Lopes AG (2000) The cystic fibrosis transmembrane regulator (CFTR) in the kidney. An Acad Bras Cienc 72:399\u2013406. https:\/\/doi.org\/10.1590\/s0001-37652000000300013","journal-title":"An Acad Bras Cienc"},{"key":"6715_CR48","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00424-008-0594-2","volume":"457","author":"F Jouret","year":"2009","unstructured":"Jouret F, Devuyst O (2009) CFTR and defective endocytosis: new insights in the renal phenotype of cystic fibrosis. Pflugers Archiv 457:1227\u20131236. https:\/\/doi.org\/10.1007\/s00424-008-0594-2","journal-title":"Pflugers Archiv"},{"key":"6715_CR49","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1681\/asn.2006030269","volume":"18","author":"F Jouret","year":"2007","unstructured":"Jouret F, Bernard A, Hermans C, Dom G, Terryn S, Leal T, Lebecque P, Cassiman JJ, Scholte BJ, de Jonge HR, Courtoy PJ, Devuyst O (2007) Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney. J Am Soc Nephrol 18:707\u2013718. https:\/\/doi.org\/10.1681\/asn.2006030269","journal-title":"J Am Soc Nephrol"},{"key":"6715_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12551-008-0002-3","volume":"1","author":"J Souza-Menezes","year":"2009","unstructured":"Souza-Menezes J, Morales MM (2009) CFTR structure and function: is there a role in the kidney? Biophys Rev 1:3\u201312. https:\/\/doi.org\/10.1007\/s12551-008-0002-3","journal-title":"Biophys Rev"},{"key":"6715_CR51","doi-asserted-by":"publisher","first-page":"F1038","DOI":"10.1152\/ajprenal.1996.270.6.F1038","volume":"270","author":"MM Morales","year":"1996","unstructured":"Morales MM, Carroll TP, Morita T, Schwiebert EM, Devuyst O, Wilson PD, Lopes AG, Stanton BA, Dietz HC, Cutting GR, Guggino WB (1996) Both the wild type and a functional isoform of CFTR are expressed in kidney. Am J Physiol 270:F1038\u2013F1048. https:\/\/doi.org\/10.1152\/ajprenal.1996.270.6.F1038","journal-title":"Am J Physiol"},{"key":"6715_CR52","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1073\/pnas.88.20.9262","volume":"88","author":"I Crawford","year":"1991","unstructured":"Crawford I, Maloney PC, Zeitlin PL, Guggino WB, Hyde SC, Turley H, Gatter KC, Harris A, Higgins CF (1991) Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci U S A 88:9262\u20139266. https:\/\/doi.org\/10.1073\/pnas.88.20.9262","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6715_CR53","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/353434a0","volume":"353","author":"AE Trezise","year":"1991","unstructured":"Trezise AE, Buchwald M (1991) In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature 353:434\u2013437. https:\/\/doi.org\/10.1038\/353434a0","journal-title":"Nature"},{"key":"6715_CR54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/hmg\/2.3.219","volume":"2","author":"EF Tizzano","year":"1993","unstructured":"Tizzano EF, Chitayat D, Buchwald M (1993) Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues. Hum Mol Genet 2:219\u2013224. https:\/\/doi.org\/10.1093\/hmg\/2.3.219","journal-title":"Hum Mol Genet"},{"key":"6715_CR55","doi-asserted-by":"publisher","first-page":"F169","DOI":"10.1152\/ajprenal.1996.271.1.F169","volume":"271","author":"O Devuyst","year":"1996","unstructured":"Devuyst O, Burrow CR, Smith BL, Agre P, Knepper MA, Wilson PD (1996) Expression of aquaporins-1 and -2 during nephrogenesis and in autosomal dominant polycystic kidney disease. Am J Physiol 271:F169\u2013F183. https:\/\/doi.org\/10.1152\/ajprenal.1996.271.1.F169","journal-title":"Am J Physiol"},{"key":"6715_CR56","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF01994360","volume":"124","author":"CE Pollard","year":"1991","unstructured":"Pollard CE, Harris A, Coleman L, Argent BE (1991) Chloride channels on epithelial cells cultured from human fetal epididymis. J Membr Biol 124:275\u2013284. https:\/\/doi.org\/10.1007\/BF01994360","journal-title":"J Membr Biol"},{"key":"6715_CR57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12551-014-0140-8","volume":"6","author":"J Souza-Menezes","year":"2014","unstructured":"Souza-Menezes J, da Silva FG, Morales MM (2014) CFTR and TNR-CFTR expression and function in the kidney. Biophys Rev 6:227\u2013236. https:\/\/doi.org\/10.1007\/s12551-014-0140-8","journal-title":"Biophys Rev"},{"key":"6715_CR58","doi-asserted-by":"publisher","first-page":"F993","DOI":"10.1152\/ajprenal.00450.2018","volume":"316","author":"YL Phua","year":"2019","unstructured":"Phua YL, Chen KH, Hemker SL, Marrone AK, Bodnar AJ, Liu X, Clugston A, Kostka D, Butterworth MB, Ho J (2019) Loss of miR-17~92 results in dysregulation of Cftr in nephron progenitors. Am J Physiol Renal Physiol 316:F993\u2013F1005. https:\/\/doi.org\/10.1152\/ajprenal.00450.2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"6715_CR59","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1073\/pnas.1213971110","volume":"110","author":"AC Brown","year":"2013","unstructured":"Brown AC, Muthukrishnan SD, Guay JA, Adams DC, Schafer DA, Fetting JL, Oxburgh L (2013) Role for compartmentalization in nephron progenitor differentiation. Proc Natl Acad Sci U S A 110:4640\u20134645. https:\/\/doi.org\/10.1073\/pnas.1213971110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6715_CR60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.devcel.2015.09.023","volume":"35","author":"MH Little","year":"2015","unstructured":"Little MH (2015) The life cycle of the nephron progenitor. Dev Cell 35:5\u20136. https:\/\/doi.org\/10.1016\/j.devcel.2015.09.023","journal-title":"Dev Cell"},{"key":"6715_CR61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.celrep.2014.02.033","volume":"7","author":"C Cebrian","year":"2014","unstructured":"Cebrian C, Asai N, D\u2019Agati V, Costantini F (2014) The number of fetal nephron progenitor cells limits ureteric branching and adult nephron endowment. Cell Rep 7:127\u2013137. https:\/\/doi.org\/10.1016\/j.celrep.2014.02.033","journal-title":"Cell Rep"},{"key":"6715_CR62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0272-6386(12)80967-X","volume":"23","author":"BM Brenner","year":"1994","unstructured":"Brenner BM, Chertow GM (1994) Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 23:171\u2013175. https:\/\/doi.org\/10.1016\/S0272-6386(12)80967-X","journal-title":"Am J Kidney Dis"},{"key":"6715_CR63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1056\/NEJMoa020549","volume":"348","author":"G Keller","year":"2003","unstructured":"Keller G, Zimmer G, Mall G, Ritz E, Amann K (2003) Nephron number in patients with primary hypertension. N Engl J Med 348:101\u2013108. https:\/\/doi.org\/10.1056\/NEJMoa020549","journal-title":"N Engl J Med"},{"key":"6715_CR64","doi-asserted-by":"publisher","first-page":"F764","DOI":"10.1152\/ajprenal.00426.2013","volume":"306","author":"JY Chu","year":"2014","unstructured":"Chu JY, Sims-Lucas S, Bushnell DS, Bodnar AJ, Kreidberg JA, Ho J (2014) Dicer function is required in the metanephric mesenchyme for early kidney development. Am J Physiol Renal Physiol 306:F764\u2013F772. https:\/\/doi.org\/10.1152\/ajprenal.00426.2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"6715_CR65","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1681\/ASN.2013040390","volume":"25","author":"AK Marrone","year":"2014","unstructured":"Marrone AK, Stolz DB, Bastacky SI, Kostka D, Bodnar AJ, Ho J (2014) MicroRNA-17~92 is required for nephrogenesis and renal function. J Am Soc Nephrol 25:1440\u20131452. https:\/\/doi.org\/10.1681\/ASN.2013040390","journal-title":"J Am Soc Nephrol"},{"key":"6715_CR66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s1569-1993(01)00004-2","volume":"1","author":"TM O'Connor","year":"2002","unstructured":"O\u2019Connor TM, McGrath DS, Short C, O\u2019Donnell MJ, Sheehy M, Bredin CP (2002) Subclinical anaemia of chronic disease in adult patients with cystic fibrosis. J Cyst Fibros 1:31\u201334. https:\/\/doi.org\/10.1016\/s1569-1993(01)00004-2","journal-title":"J Cyst Fibros"},{"key":"6715_CR67","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1515\/CCLM.2008.084","volume":"46","author":"MM Speeckaert","year":"2008","unstructured":"Speeckaert MM, Wehlou C, Vandewalle S, Taes YE, Robberecht E, Delanghe JR (2008) Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients. Clin Chem Lab Med 46:365\u2013370. https:\/\/doi.org\/10.1515\/CCLM.2008.084","journal-title":"Clin Chem Lab Med"},{"key":"6715_CR68","first-page":"131","volume":"64","author":"WA Shahin","year":"2016","unstructured":"Shahin WA, El Din Hamed DH, El Enbaby NAM et al (2016) Vitamin D and its binding protein in children with cystic fibrosis: a single center study. Egypt Pediatr Assoc Gaz 64:131\u2013135","journal-title":"Egypt Pediatr Assoc Gaz"},{"key":"6715_CR69","doi-asserted-by":"publisher","first-page":"218691","DOI":"10.1155\/2010\/218691","volume":"2010","author":"WB Hall","year":"2010","unstructured":"Hall WB, Sparks AA, Aris RM (2010) Vitamin D deficiency in cystic fibrosis. Int J Endocrin 2010:218691. https:\/\/doi.org\/10.1155\/2010\/218691","journal-title":"Int J Endocrin"},{"issue":"Suppl 2","key":"6715_CR70","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/j.jcf.2019.08.022","volume":"18","author":"T Daley","year":"2019","unstructured":"Daley T, Hughan K, Rayas M, Kelly A, Tangpricha V (2019) Vitamin D deficiency and its treatment in cystic fibrosis. J Cyst Fibros 18(Suppl 2):S66\u2013S73. https:\/\/doi.org\/10.1016\/j.jcf.2019.08.022","journal-title":"J Cyst Fibros"},{"key":"6715_CR71","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1113\/JP270087","volume":"593","author":"O Devuyst","year":"2015","unstructured":"Devuyst O, Luciani A (2015) Chloride transporters and receptor-mediated endocytosis in the renal proximal tubule. J Physiol 593:4151\u20134164. https:\/\/doi.org\/10.1113\/JP270087","journal-title":"J Physiol"},{"key":"6715_CR72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.31083\/j.fbl2702075","volume":"27","author":"G Tamma","year":"2022","unstructured":"Tamma G, Dossena S (2022) Functional interplay between CFTR and pendrin: physiological and pathophysiological relevance. Front Biosci (Landmark Ed) 27:75. https:\/\/doi.org\/10.31083\/j.fbl2702075","journal-title":"Front Biosci (Landmark Ed)"},{"key":"6715_CR73","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1113\/JP281285","volume":"599","author":"P Berg","year":"2021","unstructured":"Berg P, Svendsen SL, Sorensen MV, Schreiber R, Kunzelmann K, Leipziger J (2021) The molecular mechanism of CFTR- and secretin-dependent renal bicarbonate excretion. J Physiol 599:3003\u20133011. https:\/\/doi.org\/10.1113\/JP281285","journal-title":"J Physiol"},{"key":"6715_CR74","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1681\/ASN.2020010053","volume":"31","author":"P Berg","year":"2020","unstructured":"Berg P, Svendsen SL, Sorensen MV, Larsen CK, Andersen JF, Jensen-Fangel S, Jeppesen M, Schreiber R, Cabrita I, Kunzelmann K, Leipziger J (2020) Impaired renal HCO(3)(-) excretion in cystic fibrosis. J Am Soc Nephrol 31:1711\u20131727. https:\/\/doi.org\/10.1681\/ASN.2020010053","journal-title":"J Am Soc Nephrol"},{"key":"6715_CR75","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1874306401206010059","volume":"6","author":"F Al-Ghimlas","year":"2012","unstructured":"Al-Ghimlas F, Faughnan ME, Tullis E (2012) Metabolic alkalosis in adults with stable cystic fibrosis. Open Respir Med J 6:59\u201362. https:\/\/doi.org\/10.2174\/1874306401206010059","journal-title":"Open Respir Med J"},{"key":"6715_CR76","doi-asserted-by":"publisher","first-page":"e2116836119","DOI":"10.1073\/pnas.2116836119","volume":"119","author":"P Berg","year":"2022","unstructured":"Berg P, Andersen JF, Sorensen MV, Wang T, Malte H, Leipziger J (2022) Alkalosis-induced hypoventilation in cystic fibrosis: the importance of efficient renal adaptation. Proc Natl Acad Sci U S A 119:e2116836119. https:\/\/doi.org\/10.1073\/pnas.2116836119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6715_CR77","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1159\/000487691","volume":"45","author":"MBS Varasteh Kia","year":"2018","unstructured":"Varasteh Kia MBS, McDonough AA, Zahedi K, Xu J, Soleimani M (2018) Downregulation of the Cl\u2212\/HCO3\u2212 exchanger pendrin in kidneys of mice with cystic fibrosis: role in the pathogenesis of metabolic alkalosis. Cell Physiol Biochem 45:1551\u20131565","journal-title":"Cell Physiol Biochem"},{"key":"6715_CR78","doi-asserted-by":"publisher","first-page":"e13591","DOI":"10.1111\/apha.13591","volume":"231","author":"P Berg","year":"2021","unstructured":"Berg P, Svendsen SL, Hoang TTL, Praetorius HA, Sorensen MV, Leipziger J (2021) Impaired renal HCO(3)(-) secretion in CFTR deficient mice causes metabolic alkalosis during chronic base-loading. Acta Physiol (Oxf) 231:e13591. https:\/\/doi.org\/10.1111\/apha.13591","journal-title":"Acta Physiol (Oxf)"},{"key":"6715_CR79","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1378\/chest.124.2.490","volume":"124","author":"AE Holland","year":"2003","unstructured":"Holland AE, Wilson JW, Kotsimbos TC, Naughton MT (2003) Metabolic alkalosis contributes to acute hypercapnic respiratory failure in adult cystic fibrosis. Chest 124:490\u2013493. https:\/\/doi.org\/10.1378\/chest.124.2.490","journal-title":"Chest"},{"key":"6715_CR80","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1203\/00006450-197111000-00007","volume":"5","author":"AP Simopoulos","year":"1971","unstructured":"Simopoulos AP, Lapey A, Boat TF, Di Santagnese PA, Bartter FC (1971) The renin-angiotensin-aldosterone system in patients with cystic fibrosis of the pancreas. Pediatr Res 5:626\u2013632. https:\/\/doi.org\/10.1203\/00006450-197111000-00007","journal-title":"Pediatr Res"},{"key":"6715_CR81","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1542\/peds.101.1.48","volume":"101","author":"GJ Legris","year":"1998","unstructured":"Legris GJ, Dearborn D, Stern RC, Geiss CL, Hopfer U, Douglas JG, Doershuk CF (1998) Sodium space and intravascular volume: dietary sodium effects in cystic fibrosis and healthy adolescent subjects. Pediatrics 101:48\u201356. https:\/\/doi.org\/10.1542\/peds.101.1.48","journal-title":"Pediatrics"},{"key":"6715_CR82","doi-asserted-by":"publisher","first-page":"8382","DOI":"10.1038\/ncomms9382","volume":"6","author":"H Corvol","year":"2015","unstructured":"Corvol H, Blackman SM, Boelle PY, Gallins PJ, Pace RG, Stonebraker JR, Accurso FJ, Clement A, Collaco JM, Dang H, Dang AT, Franca A, Gong J, Guillot L, Keenan K, Li W, Lin F, Patrone MV, Raraigh KS, Sun L, Zhou YH, O\u2019Neal WK, Sontag MK, Levy H, Durie PR, Rommens JM, Drumm ML, Wright FA, Strug LJ, Cutting GR, Knowles MR (2015) Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun 6:8382. https:\/\/doi.org\/10.1038\/ncomms9382","journal-title":"Nat Commun"},{"key":"6715_CR83","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMoa051469","volume":"353","author":"ML Drumm","year":"2005","unstructured":"Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR, Gene Modifier Study G (2005) Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353:1443\u20131453. https:\/\/doi.org\/10.1056\/NEJMoa051469","journal-title":"N Engl J Med"},{"key":"6715_CR84","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1038\/s41598-017-05435-5","volume":"7","author":"JT Zhang","year":"2017","unstructured":"Zhang JT, Wang Y, Chen JJ, Zhang XH, Dong JD, Tsang LL, Huang XR, Cai Z, Lan HY, Jiang XH, Chan HC (2017) Defective CFTR leads to aberrant \u03b2-catenin activation and kidney fibrosis. Sci Rep 7:5233. https:\/\/doi.org\/10.1038\/s41598-017-05435-5","journal-title":"Sci Rep"},{"key":"6715_CR85","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ki.2010.337","volume":"79","author":"JM Lopez-Novoa","year":"2011","unstructured":"Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ (2011) New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 79:33\u201345. https:\/\/doi.org\/10.1038\/ki.2010.337","journal-title":"Kidney Int"},{"key":"6715_CR86","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1002\/ppul.25066","volume":"55","author":"A Saad","year":"2020","unstructured":"Saad A, Young MR, Studtmann AE, Autry EB, Schadler A, Beckman EJ, Gardner BM, Wurth MA, Kuhn RJ (2020) Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis. Pediatr Pulmonol 55:3384\u20133390. https:\/\/doi.org\/10.1002\/ppul.25066","journal-title":"Pediatr Pulmonol"},{"key":"6715_CR87","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/thx.2006.067595","volume":"62","author":"C Bertenshaw","year":"2007","unstructured":"Bertenshaw C, Watson AR, Lewis S, Smyth A (2007) Survey of acute renal failure in patients with cystic fibrosis in the UK. Thorax 62:541\u2013545. https:\/\/doi.org\/10.1136\/thx.2006.067595","journal-title":"Thorax"},{"key":"6715_CR88","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/BF02429057","volume":"145","author":"G Steinkamp","year":"1986","unstructured":"Steinkamp G, L\u00fctge M, Wurster U, Schulz-Baldes JG, Gr\u00f6ne HJ, Ehrich JHH (1986) Renal function in cystic fibrosis: proteinuria and enzymuria before and after tobramycin therapy. Eur J Pediatr 145:526\u2013531. https:\/\/doi.org\/10.1007\/BF02429057","journal-title":"Eur J Pediatr"},{"key":"6715_CR89","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1542-4758.2012.00675.x","volume":"16","author":"MC Florescu","year":"2012","unstructured":"Florescu MC, Lyden E, Murphy PJ, Florescu DF, Fillaus J (2012) Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis. Hemodialysis international Int Symp Home Hemodial 16:414\u2013419. https:\/\/doi.org\/10.1111\/j.1542-4758.2012.00675.x","journal-title":"Hemodialysis international Int Symp Home Hemodial"},{"key":"6715_CR90","doi-asserted-by":"publisher","first-page":"2602653","DOI":"10.1155\/2017\/2602653","volume":"2017","author":"F Stehling","year":"2017","unstructured":"Stehling F, B\u00fcscher R, Grosse-Onnebrink J, Hoyer PF, Mellies U (2017) Glomerular and tubular renal function after repeated once-daily tobramycin courses in cystic fibrosis patients. Pulm Med 2017:2602653. https:\/\/doi.org\/10.1155\/2017\/2602653","journal-title":"Pulm Med"},{"key":"6715_CR91","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41581-023-00760-7","volume":"20","author":"Y Komaru","year":"2024","unstructured":"Komaru Y, Bai YZ, Kreisel D, Herrlich A (2024) Interorgan communication networks in the kidney\u2013lung axis. Nat Rev Nephrol 20:120\u2013136. https:\/\/doi.org\/10.1038\/s41581-023-00760-7","journal-title":"Nat Rev Nephrol"},{"key":"6715_CR92","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40635-024-00672-1","volume":"12","author":"RdS Mendes","year":"2024","unstructured":"Mendes RdS, Silva PL, Robba C, Battaglini D, Lopes-Pacheco M, Caruso-Neves C, Rocco PRM (2024) Advancements in understanding the mechanisms of lung\u2013kidney crosstalk. Intens Care Med Exp 12:81. https:\/\/doi.org\/10.1186\/s40635-024-00672-1","journal-title":"Intens Care Med Exp"},{"key":"6715_CR93","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1182\/blood.2021014699","volume":"139","author":"G Wang","year":"2022","unstructured":"Wang G, Nauseef WM (2022) Neutrophil dysfunction in the pathogenesis of cystic fibrosis. Blood 139:2622\u20132631. https:\/\/doi.org\/10.1182\/blood.2021014699","journal-title":"Blood"},{"key":"6715_CR94","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.4049\/jimmunol.157.6.2728","volume":"157","author":"V Witko-Sarsat","year":"1996","unstructured":"Witko-Sarsat V, Allen RC, Paulais M, Nguyen AT, Bessou G, Lenoir G, Descamps-Latscha B (1996) Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, its correction by amiloride. J Immunol 157:2728\u20132735","journal-title":"J Immunol"},{"key":"6715_CR95","doi-asserted-by":"publisher","first-page":"L537","DOI":"10.1152\/ajplung.2000.279.3.L537","volume":"279","author":"A Van Der Vliet","year":"2000","unstructured":"Van Der Vliet A, Nguyen MN, Shigenaga MK, Eiserich JP, Marelich GP, Cross CE (2000) Myeloperoxidase and protein oxidation in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 279:L537\u2013L546. https:\/\/doi.org\/10.1152\/ajplung.2000.279.3.L537","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"6715_CR96","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1093\/ndt\/gfp079","volume":"24","author":"MT Vuong","year":"2009","unstructured":"Vuong MT, Lundberg S, Gunnarsson I, Wramner L, Seddighzadeh M, Hahn-Zoric M, Fernstrom A, Hanson LA, Do LT, Jacobson SH, Padyukov L (2009) Genetic variation in the transforming growth factor-beta1 gene is associated with susceptibility to IgA nephropathy. Nephrol Dial Transplant 24:3061\u20133067. https:\/\/doi.org\/10.1093\/ndt\/gfp079","journal-title":"Nephrol Dial Transplant"},{"key":"6715_CR97","doi-asserted-by":"publisher","first-page":"628519","DOI":"10.3389\/fmed.2021.628519","volume":"8","author":"PC Tang","year":"2021","unstructured":"Tang PC, Chan AS, Zhang CB, Garcia Cordoba CA, Zhang YY, To KF, Leung KT, Lan HY, Tang PM (2021) TGF-beta1 signaling: immune dynamics of chronic kidney diseases. Front Med (Lausanne) 8:628519. https:\/\/doi.org\/10.3389\/fmed.2021.628519","journal-title":"Front Med (Lausanne)"},{"key":"6715_CR98","doi-asserted-by":"publisher","first-page":"sfae256","DOI":"10.1093\/ckj\/sfae256","volume":"17","author":"P Gabai","year":"2024","unstructured":"Gabai P, Novel-Catin E, Reynaud Q, Nove-Josserand R, Pelletier S, Fouque D, Koppe L, Durieu I (2024) Kidney effects of triple CFTR modulator therapy in people with cystic fibrosis. Clin Kidney J 17:sfae256. https:\/\/doi.org\/10.1093\/ckj\/sfae256","journal-title":"Clin Kidney J"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06715-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06715-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06715-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:16:14Z","timestamp":1778775374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06715-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":98,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["6715"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06715-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}